88 related articles for article (PubMed ID: 32482395)
1. Population-Level Outcomes of Pediatric Acute Promyelocytic Leukemia in the United States.
Venkitachalam R; Szabo A; Guru Murthy GS
J Pediatr; 2020 Aug; 223():114-119.e5. PubMed ID: 32482395
[TBL] [Abstract][Full Text] [Related]
2. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
4. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
Hossain MJ; Xie L
Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
[TBL] [Abstract][Full Text] [Related]
5. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data.
Hossain MJ; Xie L; Caywood EH
Cancer Epidemiol; 2015 Oct; 39(5):720-6. PubMed ID: 26159683
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia: A population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017.
Sasaki K; Jabbour E; Short NJ; Jain N; Ravandi F; Pui CH; Kantarjian H
Am J Hematol; 2021 Jun; 96(6):650-658. PubMed ID: 33709456
[TBL] [Abstract][Full Text] [Related]
8. Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database.
Wang Y; Huang J; Rong L; Wu P; Kang M; Zhang X; Lu Q; Fang Y
Oncotarget; 2016 Dec; 7(50):83767-83774. PubMed ID: 27590519
[TBL] [Abstract][Full Text] [Related]
9. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
10. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
12. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
13. Leukemias, myeloma, and other lymphoreticular neoplasms.
Hernández JA; Land KJ; McKenna RW
Cancer; 1995 Jan; 75(1 Suppl):381-94. PubMed ID: 8001009
[TBL] [Abstract][Full Text] [Related]
14. Treatment advances have not improved the early death rate in acute promyelocytic leukemia.
McClellan JS; Kohrt HE; Coutre S; Gotlib JR; Majeti R; Alizadeh AA; Medeiros BC
Haematologica; 2012 Jan; 97(1):133-6. PubMed ID: 21993679
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data.
Knoble NB; Alderfer MA; Hossain MJ
Cancer Epidemiol; 2016 Oct; 44():101-108. PubMed ID: 27543948
[TBL] [Abstract][Full Text] [Related]
16. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
[TBL] [Abstract][Full Text] [Related]
17. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.
Pole JD; Darmawikarta D; Alibhai SM; Brandwein JM; Sung L
Leuk Res; 2013 Oct; 37(10):1258-64. PubMed ID: 23867057
[TBL] [Abstract][Full Text] [Related]
18. Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.
Tao Y; Yu YQ; Liu YY; Jia M; Gao L
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e7-e14. PubMed ID: 34462244
[TBL] [Abstract][Full Text] [Related]
19. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.
Zeidan AM; Podoltsev NA; Wang X; Bewersdorf JP; Shallis RM; Huntington SF; Gore SD; Davidoff AJ; Ma X; Wang R
Cancer; 2019 Dec; 125(23):4241-4251. PubMed ID: 31483484
[TBL] [Abstract][Full Text] [Related]
20. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017.
Sasaki K; Ravandi F; Kadia TM; DiNardo CD; Short NJ; Borthakur G; Jabbour E; Kantarjian HM
Cancer; 2021 Jun; 127(12):2049-2061. PubMed ID: 33818756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
